Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs TE Connectivity plc Ordinary Shares (TEL) Price & Performance

Cassava Sciences IncTrade
TE Connectivity plc Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs TE Connectivity plc Ordinary Shares — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while TE Connectivity plc Ordinary Shares trades at $215.4 (market cap $62.05B). The key difference: TE Connectivity plc Ordinary Shares is far larger — about 1574.9× Cassava Sciences Inc's market cap, and TE Connectivity plc Ordinary Shares pays a 1.46% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

FLNATEL
Market Cap
$39.40M$62.05B
Volume
759,0181,425,198
Sector
HealthTechnology
52-Week High
$4.64$249.00
52-Week Low
$0.68$195.84
Typical Hold Time
37 Days—
Enterprise Value
-$43.28M$66.44B
Dividend Yield
—1.46%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.8157, down 6.77% today, with a bearish technical signal from moving averages. The company shows improving quarterly EPS trends, beating expectations in recent quarters, though it remains unprofitable with negative ROE and ROA. Recent FDA clearance for its epilepsy drug trial provides a positive catalyst. Analyst sentiment is bullish with 67% buy ratings.

The outlook hinges on clinical progress; upside exists if Phase 2a trials succeed, but high cash burn and lack of revenue pose significant risks. Investors should weigh the strong analyst support against the company's financial challenges and binary clinical outcomes.

TE Connectivity plc Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FLNA
73% Buy27% Sell
Avg holding period · 37 Days
TEL

No sentiment data available yet.

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA →

About TE Connectivity plc Ordinary Shares

TE Connectivity designs and manufactures connectivity and sensor solutions. Its products support transportation, energy networks, industrial automation, communications infrastructure, and medical technology.

Read more on TEL →